more

Related Articles

Sprint Raises Clearwire Bid to Fend Off Dish Counteroffer
Novo Grabs Xellia Pharma for $700M
Philip Morris Buys Subsidiary Stake from Carlos Slim-Controlled Group
Cloetta Picks Up Candy Maker Goody Good Stuff
Marissa Mayer Buys Tumblr for $1.1B in Yahoo’s Biggest Deal Since 1999

SLIDESHOW

The M&A Scene: CEO Leadership
Dealmakers gathered at the Harvard Club in New York on May 7 as part of ACG NY's CEO Leadership event. Peter Gonye, a co-leader within Spencer Stuart's private equity practice in North America was the keynote speaker. Panelists included M. Tatum Pursell, senior adviser, Unlimited Horizons; Tony Ecock, general partner, Welsh Carson Anderson & Stowe; Jim Follett, former CEO of Authentic Response Inc.; Doron Grosman, operating partner, Court Square Capital; and Joelle Marquis, partner, Arsenal Capital.

Watercooler

Far Cry from the Glory Days
These days, big buyers are more likely to co-invest with limited partners

Dealmakers

Time Inc. -Meredith Pairing Would Have Been Too Complicated, Says Jeff Bewkes in Keynote
The Time Warner chairman hints there may be a future deal for the spun-off magazine business, maybe even with Meredith

Columns

The Buyside:
Trench Dealfare
Strategic players in the aerospace and defense sector look to offset losses by remaining on the hunt for targets

Today's Transactions:
Pernix Therapeutics Buys Somaxon in $25M All-Stock Deal

The target makes prescription sleep medication called Silenor

By ALLISON COLLINS
December 11, 2012

Pernix Therapeutics Holdings Inc. (NYSE: PTX) will acquire Somaxon Pharmaceuticals Inc. (Nasdaq: SOMX) in a stock-for-stock deal valued at $25 million.

Somaxon, headquartered in Solana Beach, Calif., makes Silenor, a prescription sleep medication for patients with insomnia.

Pernix is a specialty pharmaceutical company based in the Woodlands, Texas that develops generic pharmaceutical products. The company agreed to buy Cypress Pharmaceutical Inc. and Hawthorn Pharmaceuticals Inc. in November for $101 million. 

 

For more information on related topics, visit the following: